The T(14;20)(q32;q12) : A Rare Cytogenetic Change in Multiple Myeloma Associated with Poor Outcome.

被引:0
|
作者
Vekemans, Mmue-Christiane [5 ]
Lemmens, Heidi [3 ]
Doyen, Chantal [10 ]
Bries, Greet [9 ]
Demuynck, Hiide [6 ]
Pierre, Pascal [8 ]
Lemmens, Jan [7 ]
Meeus, Peter [4 ]
Delforge, Michel [2 ]
Bauwens, Deborah [1 ]
Wlodarska, Iwona [3 ]
Vandenberghe, Peter [3 ]
Michaux, Lucienne [3 ]
机构
[1] Clin St Jean, B-3000 Brussels, Belgium
[2] Univ Hosp Gasthuisberg, Louvain, Belgium
[3] Katholieke Univ Leuven, Louvain, Belgium
[4] Onze Lieve Vrouw, Clin Biol, Aalst, Belgium
[5] Clin Univ UCL St Luc, Brussels, Belgium
[6] Heilig Hart, Hematol, Roeselaere, Belgium
[7] Sint Augustinus, Hematol, Antwerp, Belgium
[8] Clin Sud Luxembourg, Hematol, Arlon, Belgium
[9] Virga Jesse, Hematol, Hasselt, Belgium
[10] Catholic Univ Louvain, Yvoir, Belgium
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:939 / 939
页数:1
相关论文
共 50 条
  • [21] 伴t(14;20)(q32;q12)易位浆细胞白血病1例并文献复习
    冯苗娟
    彭永平
    朱华锋
    苏小丽
    侯莉萍
    常子维
    高山
    于书春
    田志强
    于岩
    辛晓丽
    崔文静
    赵亚萍
    高广勋
    重庆医学, 2019, 48 (15) : 2694 - 2697
  • [22] bcl-2 translocation [t(14;18) (q32;q21)] does not correlate with poor clinical outcome in multiple myeloma patients treated with bortezomib
    Ailawadhi, Sikander
    Mashtare, Terry L.
    Coignet, Marie V.
    DePaolo, Dawn M.
    Miller, Kena C.
    Padmanabhan, Swaminathan
    Wilding, Gregory
    Starostik, Petr
    Chanan-Khan, Asher A.
    BLOOD, 2007, 110 (11) : 448A - 448A
  • [23] Clinical significance of the translocation (11;14)(q13;q32) in multiple myeloma
    Fonseca, R
    Hoyer, JD
    Aguayo, P
    Jalal, SM
    Ahmann, GJ
    Rajkumar, SV
    Witzig, TE
    Lacy, MQ
    Dispenzieri, A
    Gertz, MA
    Kyle, RA
    Greipp, PR
    LEUKEMIA & LYMPHOMA, 1999, 35 (5-6) : 599 - 605
  • [24] CHRONIC LYMPHOCYTIC LEUKEMIA WITH T(14;18)(Q32; Q21) AS A CYTOGENETIC ABNORMALITY: TWO RARE CASES
    Aslaner, M.
    Erol, B.
    Tekin, I. O.
    Ergen, S.
    Engin, H.
    Ilikhan, S.
    Bilici, M.
    Ertop, S.
    LEUKEMIA RESEARCH, 2015, 39 : SS20 - SS20
  • [25] Rapid characterisation of switch recombination events from patients with multiple myeloma and the characterisation of a novel translocation t(14;22) (q32;q12): Implications for the process of switch recombination and the pathogenesis of myeloma.
    Pratt, G
    Fenton, JAL
    Proffitt, JA
    Yates, Z
    Davies, FE
    Rawstron, AC
    Jack, AS
    Child, JA
    Morgan, GJ
    BLOOD, 1998, 92 (10) : 69A - 69A
  • [26] THE CLINICAL IMPACT OF CHROMOSOMAL TRANSLOCATION T(14;16)(Q32; Q23) IN PATIENTS WITH MULTIPLE MYELOMA
    Pavlistova, L.
    Berkova, A.
    Zemanova, Z.
    Svobodova, K.
    Izakova, S.
    Ransdorfova, S.
    Spicka, I.
    Straub, J.
    Michalova, K.
    HAEMATOLOGICA, 2017, 102 : 772 - 772
  • [27] Acute Myeloid Leukemia With a Rare t(7;14) (q21; q32) and Trisomy 4 With Poor Clinical Outcome: A Case Report
    Jabbar, Seema B.
    Monaghan, Sara
    Chen, Weina
    Koduru, Prasad
    Kumar, Kirthi
    LABORATORY MEDICINE, 2017, 48 (04) : 376 - 380
  • [28] 13q14 deletions in chronic lymphoproliferative disorders with the t(11;14)(q13;q32): A cytogenetic and interphase cytogenetic study
    Bigoni, R
    Cuneo, A
    Roberti, MG
    Bardi, A
    Rigolin, GM
    Campioni, D
    Pedriali, L
    Piva, N
    Bullrich, F
    Croce, C
    Castoldi, GL
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 144 - 144
  • [29] The (11;14)(q13;q32) translocation in multiple myeloma - A morphologic and immunohistochemical study
    Hoyer, JD
    Hanson, CA
    Fonseca, R
    Greipp, PR
    Dewald, GW
    Kurtin, PJ
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2000, 113 (06) : 831 - 837
  • [30] Translocation t(11;14)(q13;q32) is the hallmark of IgM, IgE, and nonsecretory multiple myeloma variants
    Avet-Loiseau, H
    Garand, R
    Lodé, L
    Harousseau, JL
    Bataille, R
    BLOOD, 2003, 101 (04) : 1570 - 1571